Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival - PubMed (original) (raw)
. 2007 Feb 9;282(6):3904-17.
doi: 10.1074/jbc.M605178200. Epub 2006 Dec 5.
Affiliations
- PMID: 17148450
- DOI: 10.1074/jbc.M605178200
Free article
Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival
Min-Huei Liang et al. J Biol Chem. 2007.
Free article
Abstract
Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase consisting of two isoforms, alpha and beta. The activities of GSK-3 are regulated negatively by serine phosphorylation but positively by tyrosine phosphorylation. GSK-3 inactivation has been proposed as a mechanism to promote neuronal survival. We used GSK-3 isoform-specific small interfering RNAs, dominant-negative mutants, or pharmacological inhibitors to search for functions of the two GSK-3 isoforms in regulating neuronal survival in cultured cortical neurons in response to glutamate insult or during neuronal maturation/aging. Surprisingly, RNA interference-induced depletion of either isoform was sufficient to block glutamate-induced excitotoxicity, and the resulting neuroprotection was associated with enhanced N-terminal serine phosphorylation in both GSK-3 isoforms. However, GSK-3beta depletion was more effective than GSK-3alpha depletion in suppressing spontaneous neuronal death in extended culture. This phenomenon is likely due to selective and robust inhibition of GSK-3beta activation resulting from GSK-3beta Ser9 dephosphorylation during the course of spontaneous neuronal death. GSK-3alpha silencing resulted in reduced tyrosine phosphorylation of GSK-3beta, suggesting that tyrosine phosphorylation is also a critical autoregulatory event. Interestingly, GSK-3 inhibitors caused a rapid and long-lasting increase in GSK-3alpha Ser21 phosphorylation levels, followed by a delayed increase in GSK-3beta Ser9 phosphorylation and a decrease in GSK-3alpha Tyr279 and GSK-3beta Tyr216 phosphorylation, thus implying additional levels of GSK-3 autoregulation. Taken together, our results underscore important similarities and dissimilarities of GSK-3alpha and GSK-3beta in the roles of cell survival as well as their distinct modes of regulation. The development of GSK-3 isoform-specific inhibitors seems to be warranted for treating GSK-3-mediated pathology.
Similar articles
- The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V, Vainio JC, Thompson R, Courtney MJ, Coffey ET. Hongisto V, et al. Mol Cell Biol. 2008 Mar;28(5):1515-27. doi: 10.1128/MCB.02227-06. Epub 2008 Jan 14. Mol Cell Biol. 2008. PMID: 18195042 Free PMC article. - Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation.
Liang MH, Chuang DM. Liang MH, et al. J Biol Chem. 2006 Oct 13;281(41):30479-84. doi: 10.1074/jbc.M607468200. Epub 2006 Aug 15. J Biol Chem. 2006. PMID: 16912034 - Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanism.
Russell JC, Kishimoto K, O'Driscoll C, Hossain MA. Russell JC, et al. Cell Signal. 2011 Apr;23(4):673-82. doi: 10.1016/j.cellsig.2010.11.021. Epub 2010 Dec 3. Cell Signal. 2011. PMID: 21130869 Free PMC article. - Association of glycogen synthase kinase-3β with Parkinson's disease (review).
Li DW, Liu ZQ, Chen W, Yao M, Li GR. Li DW, et al. Mol Med Rep. 2014 Jun;9(6):2043-50. doi: 10.3892/mmr.2014.2080. Epub 2014 Mar 28. Mol Med Rep. 2014. PMID: 24681994 Free PMC article. Review. - The role of glycogen synthase kinase 3 beta in multiple sclerosis.
Noori T, Dehpour AR, Sureda A, Fakhri S, Sobarzo-Sanchez E, Farzaei MH, Küpeli Akkol E, Khodarahmi Z, Hosseini SZ, Alavi SD, Shirooie S. Noori T, et al. Biomed Pharmacother. 2020 Dec;132:110874. doi: 10.1016/j.biopha.2020.110874. Epub 2020 Oct 18. Biomed Pharmacother. 2020. PMID: 33080467 Review.
Cited by
- Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice.
Omata N, Chiu CT, Moya PR, Leng Y, Wang Z, Hunsberger JG, Leeds P, Chuang DM. Omata N, et al. Int J Neuropsychopharmacol. 2011 Jun;14(5):711-7. doi: 10.1017/S1461145710000726. Epub 2010 Jul 7. Int J Neuropsychopharmacol. 2011. PMID: 20604988 Free PMC article. - Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
Maldonado H, Ramírez E, Utreras E, Pando ME, Kettlun AM, Chiong M, Kulkarni AB, Collados L, Puente J, Cartier L, Valenzuela MA. Maldonado H, et al. J Neurosci Res. 2011 Sep;89(9):1489-98. doi: 10.1002/jnr.22678. Epub 2011 Jun 10. J Neurosci Res. 2011. PMID: 21671254 Free PMC article. - Ischemia and reperfusion--from mechanism to translation.
Eltzschig HK, Eckle T. Eltzschig HK, et al. Nat Med. 2011 Nov 7;17(11):1391-401. doi: 10.1038/nm.2507. Nat Med. 2011. PMID: 22064429 Free PMC article. Review. - Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?
Scheuing L, Chiu CT, Liao HM, Linares GR, Chuang DM. Scheuing L, et al. Int J Biol Sci. 2014 Sep 10;10(9):1024-38. doi: 10.7150/ijbs.9898. eCollection 2014. Int J Biol Sci. 2014. PMID: 25285035 Free PMC article. Review. - Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.
Mines MA, Beurel E, Jope RS. Mines MA, et al. Eur J Pharmacol. 2013 Jan 5;698(1-3):252-8. doi: 10.1016/j.ejphar.2012.10.018. Epub 2012 Oct 23. Eur J Pharmacol. 2013. PMID: 23099259 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases